Alan L. Ho

Also affiliated with University of Miami

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 45 papers. Top paper: “Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma”.

Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

Journal of Clinical Oncology(2024)10.1200/jco.23.01308

N/A

1.9DataRank · unranked

94 citations

Eric J. Sherman, Heiko Schöder, Rick Wray, Jay O. Boyle, Bhuvanesh Singh +37 more

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers

The Oncologist(2022)10.1093/oncolo/oyac080

N/A

1.7DataRank · unranked

49 citations

Christina S. Baik, Jessica R. Bauman, Jill Gilbert, Marcia S. Brose, Juneko E. Grilley‐Olson +13 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa184

N/A

0.762DataRank · unranked

160 citations

Eric J. Sherman, Xin Pei, Heiko Schöder, Milan Grkovski, Ramesh Paudyal +38 more

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)

Cancer(2023)10.1002/cncr.35103

N/A

0.481DataRank · unranked

12 citations

Nathan R. Foster, Shyamprasad Deraje Vasudeva, Nora Katabi, Cristina R. Antonescu, Gary Patrick Frenette +4 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Targeting HRAS in Head and Neck Cancer

The Cancer Journal(2022)10.1097/ppo.0000000000000616

N/A

0.269DataRank · unranked

5 citations

Alan L. Ho, Antoine Desilets

[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer

EJNMMI Research(2024)10.1186/s13550-024-01138-x

N/A

0.104DataRank · unranked

1 citations

Keith S. Pentlow, Alan L. Ho, Audrey Mauguen, James A. Fagin, Nagavarakishore Pillarsetty +11 more

Randomized phase II study of sorafenib with or without everolimus in patients with radioactive iodine refractory Hürthle cell thyroid cancer (HCC) (Alliance A091302/ ITOG 1706).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6076

N/A

0DataRank · unranked

13 citations

Nathan R. Foster, Yungpo Bernard Su, Ardaman Shergill, Alan L. Ho, Bhavana Konda +4 more

Head and Neck Acinic Cell Carcinoma

The American Journal of Surgical Pathology(2022)10.1097/pas.0000000000001867

N/A

0DataRank · unranked

29 citations

Maelle Saliba, Alan L. Ho, Kartik Viswanathan, Bayan Alzumaili, Snjezana Doğan +3 more

Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6089

N/A

0DataRank · unranked

10 citations

R. Michael Tuttle, Ravinder K. Grewal, Eric J. Sherman, Shrujal S. Baxi, Laura Boucai +14 more

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2023)10.1172/jci169823

N/A

0DataRank · unranked

31 citations

Mahdi Golkaram, Joris L. Vos, Bin Xu, Conall Fitzgerald, Mark Lee +17 more

A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1030

N/A

0DataRank · unranked

26 citations

Myung‐Ju Ahn, Jameel Muzaffar, Bhumsuk Keam, Daniel W. Bowles, Deborah J. Wong +9 more

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2882

N/A

0DataRank · unranked

34 citations

Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf +8 more

Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-2586

N/A

0DataRank · unranked

24 citations

Manu Prasad, Mai Badarni, Talal Ben Lulu, Vijayasteltar Belsamma Liju, Sooraj Mathukkada +20 more

Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100150

N/A

0DataRank · unranked

16 citations

Bin Xu, Satshil Rana, Hui Chen, Ronald Ghossein, Michael F. Berger +3 more

Data from The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

(2023)10.1158/1078-0432.c.6529017.v1

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

Data from SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

(2023)10.1158/2159-8290.c.6548987.v1

N/A

0DataRank · unranked

0 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

Data from Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

(2023)10.1158/1541-7786.c.6545222.v1

N/A

0DataRank · unranked

0 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Y. Han, Fengshen Kuo +12 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions

Histopathology(2024)10.1111/his.15380

N/A

0DataRank · unranked

6 citations

Nora Katabi, Purvil Sukhadia, Kerry Mullaney, Michael Zaidinski, Jennifer R. Cracchiolo +7 more

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106861

N/A

0DataRank · unranked

8 citations

David G. Pfister, Sarah Stein, Winston Wong, Eric J. Sherman, James Fetten +6 more

Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma

Oral Oncology(2024)10.1016/j.oraloncology.2024.106688

N/A

0DataRank · unranked

6 citations

Kushal Suryamohan, Nara Shin, Sooraj Mathukkada, Alexandra Boyko, Daria Melikhova +18 more

Detection of SEZ6, a Therapeutic Target, in Medullary Thyroid Carcinoma

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae672

N/A

0DataRank · unranked

4 citations

Marina K. Baine, Achim A. Jungbluth, Anas Alabkaa, Rene Serrette, Dibisha Roy +8 more

Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors

Oncogene(2024)10.1038/s41388-024-03095-0

N/A

0DataRank · unranked

2 citations

Gnana P. Krishnamoorthy, Walid K. Chatila, Katherine Berman, Mahesh Saqcena, Henry Walch +6 more

Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations

Head and Neck Pathology(2024)10.1007/s12105-024-01694-7

N/A

0DataRank · unranked

1 citations

Bin Xu, Purvil Sukhadia, Abhinita Mohanty, Sara DiNapoli, Alan L. Ho +3 more

Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(25)00064-6

N/A

0DataRank · unranked

28 citations

Laura Boucai, Naifa L. Busaidy, Cosimo Durante, James A. Fagin, Sasan Fazeli +12 more

Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy

Cancer Treatment Reviews(2025)10.1016/j.ctrv.2025.102891

N/A

0DataRank · unranked

13 citations

Alan L. Ho, Kathleen Moore, Seth M. Pollack, Jean-Marc Navenot, Joseph P. Sanderson +1 more

Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer

Oral Oncology(2025)10.1016/j.oraloncology.2025.107349

N/A

0DataRank · unranked

9 citations

Michael T. Starc, Richard J. Wong, Alan L. Ho, Ian Ganly, David G. Pfister +6 more

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression

The Journal of Experimental Medicine(2025)10.1084/jem.20242250

N/A

0DataRank · unranked

6 citations

Boris Reva, Nora Katabi, Avishai Wizel, Hong-Bo Xu, Alan L. Ho +7 more

Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case–control study

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101352

N/A

0DataRank · unranked

2 citations

Teeradon Treechairusame, Amir H. Safavi, Yingzhi Wu, Zhigang Zhang, A. Shamseddine +11 more

Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.27.635086

N/A

0DataRank · unranked

2 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.6103

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Anuja Kriplani, James Fetten, Loren S. Michel, Michael Hwang +6 more

Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers

Journal of Clinical Investigation(2025)10.1172/jci191781

N/A

0DataRank · unranked

0 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology(2025)10.1016/j.oraloncology.2025.107524

N/A

0DataRank · unranked

0 citations

Alan L. Ho, Loren S. Michel, Winston Wong, Juliana Eng, Iris Zhi +9 more

Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure

Head & Neck(2025)10.1002/hed.70078

N/A

0DataRank · unranked

1 citations

Teeradon Treechairusame, Nadeem Riaz, Sean M. McBride, Daphna Y. Gelblum, A. Shamseddine +10 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3758

N/A

0DataRank · unranked

126 citations

Fengshen Kuo, Nora Katabi, Mark Lee, Zaineb Nadeem, Martin G. Dalin +11 more

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0735

N/A

0DataRank · unranked

109 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CT

Clinical Nuclear Medicine(2020)10.1097/rlu.0000000000003141

N/A

0DataRank · unranked

4 citations

Iva Petkovska, Alan L. Ho, Gary A. Ulaner, Simone Krebs

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more

Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0442

N/A

0DataRank · unranked

20 citations

Brian R. Untch, Bin Xu, Ronald Ghossein, Catherine Han, Fengshen Kuo +12 more

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers

Endocrine Related Cancer(2021)10.1530/erc-21-0017

N/A

0DataRank · unranked

18 citations

Jennifer R. Cracchiolo, Gnana P. Krishnamoorthy, Luis J. Leandro‐García, James Nagarajah, Mahesh Saqcena +11 more

ERBB2 amplification status in 67 salivary duct carcinomas assessed by immunohistochemistry, fluorescence in situ hybridization, and targeted exome sequencing

Modern Pathology(2021)10.1038/s41379-021-00999-0

N/A

0DataRank · unranked

12 citations

Amir Momeni Boroujeni, Tao Zheng, Abhinita Mohanty, Alan L. Ho, Maria E. Arcila +3 more